Brief: Abbvie Reaffirms FY Adj Diluted EPS Guidance Range $10.71-$10.91

Cerevel Therapeutics Holdings

01/08/2024 13:26

Aug 1 (Reuters) - Abbvie Inc  ABBV.N :
    * ABBVIE: REAFFIRMS PREVIOUSLY ISSUED 2024 FULL-YEAR
ADJUSTED
DILUTED EPS GUIDANCE RANGE OF $10.71-$10.91
    * ABBVIE: REAFFIRMS Q3 ADJUSTED DILUTED EPS GUIDANCE RANGE
OF
$2.92-$2.96
    * ABBVIE COMPLETES ACQUISITION OF CEREVEL THERAPEUTICS

Further company coverage:  ABBV.N 

 ((Reuters.Briefs@thomsonreuters.com;))